1302pdifct-1502 CLINIVO: Real-Life Experience With Nivolumab in 600 Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC): Efficacy and Safety of Nivolumab and Post-Nivolumab Treatment in the French Expanded Access Program (EAP)
Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdx380.005
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2017
Authors
Publisher
Elsevier BV